|
SAMD1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | <1E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
<1E-12 |
| Normal-vs-Stage2 |
1.63170033040672E-10 |
| Normal-vs-Stage3 |
1.62436730732907E-12 |
| Normal-vs-Stage4 |
<1E-12 |
| Stage1-vs-Stage2 |
1.399410E-01 |
| Stage1-vs-Stage3 |
3.682000E-01 |
| Stage1-vs-Stage4 |
5.321000E-03 |
| Stage2-vs-Stage3 |
5.600400E-02 |
| Stage2-vs-Stage4 |
2.396100E-03 |
| Stage3-vs-Stage4 |
5.290000E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62447832963153E-12 |
| Normal-vs-AfricanAmerican |
7.06309455367204E-11 |
| Normal-vs-Asian |
1.62447832963153E-12 |
| Caucasian-vs-AfricanAmerican |
5.294600E-01 |
| Caucasian-vs-Asian |
3.610800E-01 |
| AfricanAmerican-vs-Asian |
1.948430E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.62447832963153E-12 |
| Normal-vs-Female |
<1E-12 |
| Male-vs-Female |
4.744200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
<1E-12 |
| Normal-vs-Age(41-60Yrs) |
<1E-12 |
| Normal-vs-Age(61-80Yrs) |
<1E-12 |
| Normal-vs-Age(81-100Yrs) |
5.634500E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.131600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.998600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.085400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.069600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.429000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.762600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
8.275000E-01 |
| Classical-VS-Follicular |
6.91247059592115E-12 |
| Classical-VS-Other |
8.541600E-01 |
| Classical-VS-Normal |
1.62436730732907E-12 |
| Tall-VS-Follicular |
3.31409999998478E-06 |
| Tall-VS-Other |
9.407800E-01 |
| Tall-VS-Normal |
4.44089209850063E-16 |
| Follicular-VS-Other |
2.646200E-02 |
| Follicular-VS-Normal |
3.7908565175826E-12 |
| Other-VS-Normal |
2.180900E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.62447832963153E-12 |
| Normal-vs-N1 |
1.67499347725197E-12 |
| N0-vs-N1 |
6.528200E-01 |
|
|
